We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05188664
Recruitment Status : Enrolling by invitation
First Posted : January 12, 2022
Last Update Posted : May 23, 2022
Information provided by (Responsible Party):
LaNova Medicines Limited ( LaNova Australia Pty Limited )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : October 1, 2023
Estimated Study Completion Date : March 1, 2024